ESC Professional Premium Access

Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: Real-world data from OPUS and OrPHeUS

Congress Presentation

About the speaker

Professor Richard Channick

David Geffen School of Medicine at UCLA, Los Angeles (United States of America)
0 follower

4 more presentations in this session

Pulmonary arterial hypertension associated with congenital heart disease: real-world analysis of clinical characteristics, treatment patterns and outcomes from EXPOSURE

Speaker: Doctor M. Escribano Subias (Madrid, ES)

Thumbnail

Characterisation of pulmonary arterial hypertension patients with cardiovascular comorbidities treated with selexipag: real-world evidence from the EXPOSURE study

Speaker: Professor S. Soderberg (Umea, SE)

Thumbnail

Incident pulmonary hypertension in 13,448 cases investigated with repeat echocardiography: insight from the national echo database of australia (NEDA)

Speaker: Professor S. Stewart (Adelaide, AU)

Thumbnail

Paediatric pulmonary arterial hypertension following congenital heart defect repair: enhanced risk stratification and outcomes in a national cohort

Speaker: Doctor A. Constantine (London, GB)

Thumbnail

Access the full session

Pulmonary hypertension around the real world

Speakers: Professor R. Channick, Doctor M. Escribano Subias, Professor S. Soderberg, Professor S. Stewart, Doctor A. Constantine
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk